Abiopharma

Relmada Therapeutics Joins Russell2000® and Russell 3000® Indexes

Gilat Receives $43 Million of Additional Sidewinder ESA Orders from Leading In-flight Connectivity Service Provider

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Palladyne AI’s GuideTech Wins New $2.3 Million Contract for BRAIN with Defense Prime Continuing Commercial Momentum

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET

Perma-Pipe Joins Russell 2000 and Russell 3000 Indexes

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes

Russell Indexes Add Z Squared Inc. to Russell 2000® and Russell 3000®

Sharon AI Announces Closing of US$1.6 Billion Strategic Financing